Header Logo

Connection

Adrian Puren to Anti-HIV Agents

This is a "connection" page, showing publications Adrian Puren has written about Anti-HIV Agents.
Connection Strength

2,525
  1. Progress towards the UNAIDS 95-95-95 targets among pregnant women in South Africa: Results from the 2017 and 2019 national Antenatal HIV Sentinel Surveys. PLoS One. 2022; 17(7):e0271564.
    View in: PubMed
    Score: 0,427
  2. Recency of HIV infection, antiretroviral therapy use and viral loads among symptomatic sexually transmitted infection service attendees in South Africa. S Afr Med J. 2022 Feb 01; 112(2):13502.
    View in: PubMed
    Score: 0,413
  3. Coverage of maternal viral load monitoring during pregnancy in South Africa: Results from the 2019 national Antenatal HIV Sentinel Survey. HIV Med. 2021 10; 22(9):805-815.
    View in: PubMed
    Score: 0,397
  4. HIV viral load non-suppression and associated factors among pregnant and postpartum women in rural northeastern South Africa: a cross-sectional survey. BMJ Open. 2022 03 10; 12(3):e058347.
    View in: PubMed
    Score: 0,104
  5. HIV care coverage among HIV-positive adolescent girls and young women in South Africa: Results from the HERStory Study. S Afr Med J. 2021 Apr 30; 111(5):460-468.
    View in: PubMed
    Score: 0,098
  6. Impact of breastfeeding, maternal antiretroviral treatment and health service factors on 18-month vertical transmission of HIV and HIV-free survival: results from a nationally representative HIV-exposed infant cohort, South Africa. J Epidemiol Community Health. 2020 12; 74(12):1069-1077.
    View in: PubMed
    Score: 0,094
  7. Successes and gaps in the HIV cascade of care of a high HIV prevalence setting in Zimbabwe: a population-based survey. J Int AIDS Soc. 2020 09; 23(9):e25613.
    View in: PubMed
    Score: 0,094
  8. The role of drug resistance in poor viral suppression in rural South Africa: findings from a population-based study. BMC Infect Dis. 2020 Mar 26; 20(1):248.
    View in: PubMed
    Score: 0,091
  9. Viral suppression and factors associated with failure to achieve viral suppression among pregnant women in South Africa. AIDS. 2020 03 15; 34(4):589-597.
    View in: PubMed
    Score: 0,091
  10. Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13. BMC Infect Dis. 2019 Sep 16; 19(Suppl 1):787.
    View in: PubMed
    Score: 0,088
  11. Improvements in the South African HIV care cascade: findings on 90-90-90 targets from successive population-representative surveys in North West Province. J Int AIDS Soc. 2019 06; 22(6):e25295.
    View in: PubMed
    Score: 0,086
  12. Provincial and national prevalence estimates of transmitted HIV-1 drug resistance in South Africa measured using two WHO-recommended methods. Antivir Ther. 2019; 24(3):203-210.
    View in: PubMed
    Score: 0,083
  13. Knowledge of HIV status and antiretroviral therapy use among sexually transmitted infections service attendees and the case for improving the integration of services in South Africa: A cross sectional study. Medicine (Baltimore). 2018 Sep; 97(39):e12575.
    View in: PubMed
    Score: 0,081
  14. Population-level effectiveness of PMTCT Option A on early mother-to-child (MTCT) transmission of HIV in South Africa: implications for eliminating MTCT. J Glob Health. 2016 Dec; 6(2):020405.
    View in: PubMed
    Score: 0,072
  15. Level of viral suppression and the cascade of HIV care in a South African semi-urban setting in 2012. AIDS. 2016 08 24; 30(13):2107-16.
    View in: PubMed
    Score: 0,071
  16. First population-level effectiveness evaluation of a national programme to prevent HIV transmission from mother to child, South Africa. J Epidemiol Community Health. 2015 Mar; 69(3):240-8.
    View in: PubMed
    Score: 0,062
  17. Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance. AIDS. 2009 Apr 27; 23(7):809-16.
    View in: PubMed
    Score: 0,043
  18. Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine. J Acquir Immune Defic Syndr. 2007 Feb 01; 44(2):148-53.
    View in: PubMed
    Score: 0,037
  19. Investigation of HIV in amniotic fluid from HIV-infected pregnant women at full term. J Infect Dis. 2005 Aug 01; 192(3):488-91.
    View in: PubMed
    Score: 0,033
  20. Progress of UNAIDS 90-90-90 targets in a district in KwaZulu-Natal, South Africa, with high HIV burden, in the HIPSS study: a household-based complex multilevel community survey. Lancet HIV. 2017 11; 4(11):e505-e513.
    View in: PubMed
    Score: 0,019
  21. Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa. BMC Public Health. 2015 Nov 20; 15:1149.
    View in: PubMed
    Score: 0,017
  22. Missed Opportunities along the Prevention of Mother-to-Child Transmission Services Cascade in South Africa: Uptake, Determinants, and Attributable Risk (the SAPMTCTE). PLoS One. 2015; 10(7):e0132425.
    View in: PubMed
    Score: 0,016
  23. Development of phenotypic HIV-1 drug resistance after exposure to single-dose nevirapine. J Acquir Immune Defic Syndr. 2008 Dec 15; 49(5):538-43.
    View in: PubMed
    Score: 0,010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.